Global cancer burden, growing amidst mounting need for services. WHO. https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services. Accessed 19 Jan 2024.

International Agency for Research on Cancer: All cancers. https://gco.iarc.fr/today/data/factsheets/cancers/39-All-cancers-fact-sheet.pdf. Accessed 19 Jan 2024.

Siegel RL, Miller KD, Wagle NS, et al. CA: A Cancer Journal for Clinicians. Cancer Stat. 2023;73(1):17–48. https://doi.org/10.3322/caac.21763.

Article  Google Scholar 

Berger NA, Savvides P, Koroukian SM, et al. Cancer in the elderly. Trans Am Clin Climatol Assoc 2006;147–156

WHO Model List of Essential Medicines: 20th List (April 2017). 26–31. http://www.who.int/medicines/publications/essentialmedicines/en/. Accessed 19 Jan 2023.

Dahan R. Monoclonal antibodies, antibody-drug conjugates, and specific antibodies. Cancer Research Institute. https://www.cancerresearch.org/immunotherapy/treatment-types/targeted-antibodies. Accessed 19 Jan 2024.

Types of cancer treatment. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types. Accessed 20 Jan 2024.

National Cancer Institute (NCI). Immunotherapy to treat cancer. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy. Accessed 20 Jan 2024.

Tran E, Robbins PF, Lu Y-C, et al. T-cell transfer therapy targeting mutant KRAS in cancer. Engl J Med. 2016;375(23):2255–62.

CAS  Google Scholar 

DeMaria PJ, Bilusic M. Cancer Vaccines. Hematol Oncol Clin North Am. 2019;33(2):199–214.

PubMed  Google Scholar 

Almost half of oncology drugs approved since 1998 have been Precision therapies, new study shows. The ASCO Post staff. 10/19/2023. https://ascopost.com/news/october-2023/almost-half-of-oncology-drugs-approved-since-1998-have-been-precision-therapies-new-study-finds/. Accessed 1 Feb 2024.

Manis JP. Overview of therapeutic monoclonal antibodies, in UpToDate ed Furst DE, Nov 2020

Baldo BA. Monoclonal antibodies approved for cancer therapy in Safety of Biologics Therapy. Cham: Springer, 2016;57–140.

DeMaria PJ, Bilusic M. Cancer Vaccines. Op. Cit

American Cancer Society. Cancer Treatment & Survivorship Facts & Figures 2019–2021. Atlanta: American Cancer Society; 2019. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-treatment-and-survivorship-facts-and-figures/cancer-treatment-and-survivorship-facts-and-figures-2019-2021.pdf. Accessed 1 Feb 2024.

Guidelines International Network. https://guidelines.ebmportal.com/guidelines-international-network?search=cancer&type=search. Accessed 1 Feb 2024.

Balducci L, Cohen HJ, Engstrom PF, et al. Senior adult oncology clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2005;3(4):572–90.

PubMed  Google Scholar 

Grilli R, Magrini N, Penna A, et al. Practice guidelines developed by specialty societies: the need for critical appraisal. The Lancet. 2000;355(9198):103–6.

CAS  Google Scholar 

ESMO Clinical Practice Guidelines. https://www.esmo.org/guidelines. Accessed 1 Feb 2024.

National Comprehensive Cancer Network. NCCN Guidelines & Clinical Resources: NCCN Guidelines. https://www.nccn.org/professionals/physician_gls/default.aspx. Accessed 15 Feb 2024.

Institute of Medicine. Dying in America: Improving quality and honoring individual preferences near the end of life. Washington, DC: National Academies Press; 2014.

Google Scholar 

The World Health Organization Quality of Life (WHOQOL). https://www.who.int/toolkits/whoqol. Accessed 15 Feb 2024.

Caring for someone in their last days and hours: Marie Curie. https://www.mariecurie.org.uk/professionals/palliative-care-knowledge-zone/final-days/caring-last-days. Accessed 1 Mar 2024.

Approaching death: Improving care at the End of Life. Institute of Medicine (US) Committee on Care at the End of Life; Field MJ, Cassel CK, editors. Washington (DC): National Academies Press (US); 1997. https://www.ncbi.nlm.nih.gov/books/NBK233591/. Accessed 1 Mar 2024.

End-of-Life care for people who have cancer. NCI. https://www.cancer.gov/about-cancer/advanced-cancer/care-choices/care-fact-sheet. Accessed 1 Mar 2024.

Making decisions and managing your treatment: If cancer treatments stop. Am Cancer Soc. https://www.cancer.org/treatment/treatments-and-side-effects/planning-managing/if-cancer-treatments-stop-working.html. Accessed 8 Mar 2024.

NCCN Guidelines & Clinical Resources: NCCN guidelines for supportive care. http://www.nccn.org/professionals/physician_gls/PDF/palliative.pdf. Accessed 8 Mar 2024.

Guidelines, Tools, & Resources. ASCO. https://www.asco.org/research-guidelines/quality-guidelines/guidelines. Accessed 8 Mar 2024.

NCCN Recently Updated Guidelines: Supportive care, 2024. https://www.nccn.org/guidelines/category_3. Accessed 8 Mar 2024.

Jacobsen J, Jackson VA. A communication approach for Oncologist: Understanding patient coping and communicating about bad news, Palliative care, and Hospice. J Natl Compr Canc Netw. 2009;7(4):475–80.

PubMed  Google Scholar 

Li Mo, Urbauer DL, Bruera E, et al. Recommendations for palliative and hospice care in NCCN Guidelines for Treatment of Cancer. The Oncologist. 2021;26:77–83.

Google Scholar 

Zaman S, Inbadas H, Whitelaw A, et al. Common or multiple futures for end-of-life care around the world: Ideas from the ‘waiting room of history.’ Soc Sci Med. 2017;172:72–9.

PubMed  PubMed Central  Google Scholar 

Stevens J. A pathway to euthanasia? Family revives father doctors ruled wasn’t worth saving. Daily Mail; Feb 13, 2013 http://www.dailymail.co.uk/news/article-2217061/Liverpool-Care-Pathway-Family-revive-man-doctors-wasnt-worth-savinghtml. Accessed 8 Mar 2024.

More care, less pathway: A review of the Liverpool Care Pathway: Department of Health, London, 2013. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/212450/Liverpool_Care_Pathway.pdf. Accessed 8 Mar 2024.

Wikipedia contributors. Death panel. Wikipedia, The Free Encyclopedia. 2020. https://en.wikipedia.org/w/index.php?title=Death_panel&oldid=992320301. Accessed 9 Mar 2024.

Faguet GB. The affordable care act: A missed opportunity. A better way forward: Algora Publishing; 2013.

Google Scholar 

History of the Aktion T4: Nazi program for involuntary euthanasia; The murder of thousands of disabled and psychiatric patients, 2020. https://www.normandy1944.info/holocaust/aktion-t4. Accessed 9 Mar 2024.

Malin JL. Bridging the divide: Integrating cancer-directed therapy and palliative care. J Clin Oncol. 2004;22(17):3438–40.

PubMed  Google Scholar 

Bekelman JE, Halpern SD, Blankart CR, et al. Comparison of site of death, healthcare utilization, and hospital expenditures for patients dying with Cancer in 7 developed countries. JAMA. 2016;315(3):272–83.

CAS  PubMed  Google Scholar 

Tang ST, Wu S-C, Hung Y-N, et al. Trends in quality of end-of-life care for Taiwanese cancer patients who died in 2000–2006. Ann Oncol. 2009;20(2):343–8.

CAS  PubMed  Google Scholar 

Lee HS, Chun KH, Moon D, et al. Trends in receiving chemotherapy for advanced cancer patients at the end of life. BMC Palliat Care. 2015;14:4.

PubMed  PubMed Central  Google Scholar 

Chastek B, Harley C, Kallich J, et al. J Oncol Pract. 2012;8(6):75s–80s.

PubMed  PubMed Central  Google Scholar 

Vestergaard AHS, Neergard MA, Christiansen CF, et al. Hospitalization at the end of life among cancer and non-cancer patients in Denmark: A nationwide register-based cohort study. BMJ Open. 2020;10:e033493.

PubMed  PubMed Central  Google Scholar 

Merchant SJ, Lajkosz K, Brody SB, et al. The final 30 days of life: A study of patients with gastrointestinal cancer in Ontario. Canada J Palliat Care. 2017;32(3–4):92–100.

PubMed  Google Scholar 

Egan PC, LeBlanc Olszewski TW. End-of-life care quality outcomes among Medicare beneficiaries with hematologic malignancies. Blood Adv. 2020;4(15):3606–14.

PubMed  PubMed Central  Google Scholar 

Gomes B, Calanzani N, Gysels M, et al. Heterogeneity and changes in preferences for dying at home: a systematic review. BMC Palliat Care. 2013;12:7.

PubMed  PubMed Central  Google Scholar 

Earle CC, Park ER, Lai B, et al. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol. 2003;21(6):1133–8.

PubMed  Google Scholar 

Lamont EB, Christakis NA. Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med. 2001;134(12):1096–10105.

CAS  PubMed  Google Scholar 

Gorman TE, Ahern SP, Wiseman J, et al. Residents’ end-of-life decision making with adult hospitalized patients: a review of the literature. Acad Med. 2005;80:622–33.

PubMed  Google Scholar 

Karnofsky D, Burchenal J. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod C, editor. Evaluation of Chemotherapeutic Agents. New York, NY: Columbia University Press; 1949. p. 191–205.

Google Scholar 

Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–55.

CAS  PubMed  Google Scholar 

Soares da Silva L, Rocha S, Riechelmann RP. Treatment of patients with metastatic colorectal cancer and poor performance and status: current evidence and challenges. Clinics (Sao Paulo). 2018;73(1):e542s.

Google Scholar 

Aaronson NK, Ahmedzai S, Bergman B, et al. The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.

CAS  PubMed  Google Scholar 

Guerra-Farfan E, Garcia-Sanchez Y, Jornet-Gilbert M, et al. Clinical practice guidelines: Thee good, the bad, and the ugly. 2023. https://www.sciencedirect.com/science/article/abs/pii/S0020138322000778. Accessed 1 May 2024.

Braga S. Why do our patients get chemotherapy until the end of life? Ann Oncol. 2011;22:2345–8.

CAS  PubMed  Google Scholar 

Khatcheressian J, Harrington SB, Lyckholm LJ, et al. ‘Futile Care’: What to do when your patient insists on chemotherapy that likely won’t help. Oncology. 2008;22(8):881–8.

PubMed  Google Scholar 

NHPCO Facts and Figures, 2021 Edition https://wpln.org/wp-content/uploads/sites/7/2021/12/NHPCO-Facts-Figures-2021-edition-1.pdf. Accessed 1 May 2024.

Anshushaug M, Gynnild MA, Kaasa S, et al. Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway. Acta Oncol. 2015;54(3):395–402.

CAS  PubMed  Google Scholar 

Akhalghi E, Lehto RH, Torabikhah M, et al. Chemotherapy use and quality of life in cancer patients at the end of life: an integrative review. Health Qual Life Outcomes. 2020;18:332.

Google Scholar 

Arciero V, DeLos SS, Koshy L, et al. Assessment of Food and Drug Administration– and European Medicines Agency–approved Systemic oncology therapies and clinically meaningful improvements in quality of life: A systematic review. JAMA Netw Open. 2021;4(2):e20033004.

Google Scholar 

Prasad V, Kim MS. Approval and Coverage of Cancer Drugs in England, Canada, and the US. JAMA Intern Med. 2021;181(4):509. https://doi.org/10.1001/jamainternmed.2020.8587.

Article  PubMed  Google Scholar 

Samuel JN, Booth CM, Eisenhauer E, et al. Association of Quality-of-Life Outcomes in Cancer Drug Trials With Survival Outcomes and Drug Class. JAMA Oncol. 2022;8(6):879–86.

PubMed